A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
A study to verify the superiority of ramosetron hydrochloride (Irribow Tablets) to placebo for male patients with diarrhea-predominant irritable bowel syndrome (D-IBS) and to evaluate its safety.
Epistemonikos ID: 19c3b46bf5b988115bd6ce40e34ea2affc7a1d2a
First added on: May 06, 2024